A decrease in the induction of MMP-2 and cell migration following a block in the phosphorylation of MAP kinase p38 was observed upon in vitro and in vivo treatment of prostate cancer cells with the isoflavone genistein [190,191]. Here, MAPK1 is linked to prostate cancer.